BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17078383)

  • 1. Gene therapy for chronic granulomatous disease.
    Stein S; Siler U; Ott MG; Seger R; Grez M
    Curr Opin Mol Ther; 2006 Oct; 8(5):415-22. PubMed ID: 17078383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy of chronic granulomatous disease (CGD) by gene transfer into hematopoietic stem cells.
    Zentilin L; Tafuro S; Serra C; Falaschi A; Giacca M
    Ann Ist Super Sanita; 1998; 34(4):447-55. PubMed ID: 10234875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gene therapy for inherited diseases using heamatopoietic stem cells--gene therapy for patients with chronic granulomatous disease].
    Nunoi H; Ishibashi F
    Hum Cell; 1999 Sep; 12(3):103-8. PubMed ID: 10695016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for chronic granulomatous disease.
    Kume A; Dinauer MC
    J Lab Clin Med; 2000 Feb; 135(2):122-8. PubMed ID: 10695656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in gene therapy for chronic granulomatous disease.
    Malech HL
    J Infect Dis; 1999 Mar; 179 Suppl 2():S318-25. PubMed ID: 10081502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of genetically corrected neutrophils in chronic granulomatous disease mice by cotransferring a therapeutic gene and a selective amplifier gene.
    Hara T; Kume A; Hanazono Y; Mizukami H; Okada T; Tsurumi H; Moriwaki H; Ueda Y; Hasegawa M; Ozawa K
    Gene Ther; 2004 Sep; 11(18):1370-7. PubMed ID: 15229634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for chronic granulomatous disease.
    Kang EM; Malech HL
    Methods Enzymol; 2012; 507():125-54. PubMed ID: 22365772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress toward effective gene therapy for chronic granulomatous disease.
    Malech HL; Choi U; Brenner S
    Jpn J Infect Dis; 2004 Oct; 57(5):S27-8. PubMed ID: 15507764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modern management of chronic granulomatous disease.
    Seger RA
    Br J Haematol; 2008 Feb; 140(3):255-66. PubMed ID: 18217895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.
    Ott MG; Schmidt M; Schwarzwaelder K; Stein S; Siler U; Koehl U; Glimm H; Kühlcke K; Schilz A; Kunkel H; Naundorf S; Brinkmann A; Deichmann A; Fischer M; Ball C; Pilz I; Dunbar C; Du Y; Jenkins NA; Copeland NG; Lüthi U; Hassan M; Thrasher AJ; Hoelzer D; von Kalle C; Seger R; Grez M
    Nat Med; 2006 Apr; 12(4):401-9. PubMed ID: 16582916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful bone marrow transplantation in an 8-month-old patient with chronic granulomatous disease.
    Kansoy S; Kütükçüler N; Aksoylar S; Aksu G; Kantar M; Cetingül N
    Turk J Pediatr; 2006; 48(3):253-5. PubMed ID: 17172071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature.
    Del Giudice I; Iori AP; Mengarelli A; Testi AM; Romano A; Cerretti R; Macrì F; Iacobini M; Arcese W
    Ann Hematol; 2003 Mar; 82(3):189-92. PubMed ID: 12634956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress towards hematopoietic stem cell gene therapy.
    Kurre P; Kiem HP
    Curr Opin Mol Ther; 2000 Aug; 2(4):400-11. PubMed ID: 11249770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First successful bone marrow transplantation for X-linked chronic granulomatous disease by using preimplantation female gender typing and HLA matching.
    Reichenbach J; Van de Velde H; De Rycke M; Staessen C; Platteau P; Baetens P; Güngör T; Ozsahin H; Scherer F; Siler U; Seger RA; Liebaers I
    Pediatrics; 2008 Sep; 122(3):e778-82. PubMed ID: 18762514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory complications after haematopoietic stem cell transplantation in a patient with chronic granulomatous disease.
    Hara K; Kajiume T; Kondo T; Sera Y; Kawaguchi H; Kobayashi M
    Transfus Med; 2009 Apr; 19(2):105-8. PubMed ID: 19320854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancer-deleted retroviral vectors restore high levels of superoxide generation in a mouse model of CGD.
    Schwickerath O; Brouns G; Thrasher A; Kinnon C; Roes J; Casimir C
    J Gene Med; 2004 Jun; 6(6):603-15. PubMed ID: 15170731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the treatment of Chronic Granulomatous Disease by gene therapy.
    Ott MG; Seger R; Stein S; Siler U; Hoelzer D; Grez M
    Curr Gene Ther; 2007 Jun; 7(3):155-61. PubMed ID: 17584034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity of repeated intravenous injection of gene therapeutics for X-CGD in mice.
    Lee YM; Choi WH; Kim YB; Ha CS; Song CW; Lee M; Joo CW; Hong Y; Ho SH; Kim S; Kim JM; Koh WS
    Hum Exp Toxicol; 2008 May; 27(5):401-7. PubMed ID: 18715886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated gene transfer into monocyte-derived macrophages of patients with X-linked chronic granulomatous disease: ex vivo correction of deficient respiratory burst.
    Schneider SD; Rusconi S; Seger RA; Hossle JP
    Gene Ther; 1997 Jun; 4(6):524-32. PubMed ID: 9231068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgene optimization significantly improves SIN vector titers, gp91phox expression and reconstitution of superoxide production in X-CGD cells.
    Moreno-Carranza B; Gentsch M; Stein S; Schambach A; Santilli G; Rudolf E; Ryser MF; Haria S; Thrasher AJ; Baum C; Brenner S; Grez M
    Gene Ther; 2009 Jan; 16(1):111-8. PubMed ID: 18784749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.